Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic mucocutaneous candidiasis.

C H Kirkpatrick1

  • 1Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|May 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.

Clinical and experimental immunology·2014
Same author

Chronic mucocutaneous candidiasis.

The Pediatric infectious disease journal·2001
Same author

Transfer factors: identification of conserved sequences in transfer factor molecules.

Molecular medicine (Cambridge, Mass.)·2000
Same author

Eleventh International Congress on Transfer Factors: March 1-4, 1999, Monterrey, Nuevo Leon, Mexico.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2000
Same author

Recognition of the immunocompromised patient.

Chest surgery clinics of North America·1999
Same author

A man with multiple infections with unusual organisms.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·1999
Same journal

Adaptive susceptibility shifts in Candidozyma auris following biocidal exposure: Exploratory effects on antifungal and biocidal susceptibility.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Prevalence and risk factors of sexually transmitted infections in women in eleven hospitals in two low-income countries: a cross-sectional study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Tetracycline for Helicobacter pylori eradication: a narrative review from quadruple to dual therapy.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Breaking barriers: Implementation of a tuberculosis preventive treatment protocol among newly eligible populations with promising results.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

A qPCR identification scheme to differentiate actinomycetoma from eumycetoma.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

In-depth analysis of sampling practice and yield of blood cultures.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
See all related articles

Chronic mucocutaneous candidiasis involves persistent Candida albicans infections due to impaired cell-mediated immunity. Correcting these immune defects is crucial for long-term recovery from fungal infections.

Area of Science:

  • Immunology
  • Dermatology
  • Infectious Diseases

Background:

  • Chronic mucocutaneous candidiasis (CMC) is characterized by recurrent infections of the skin, nails, and mucous membranes caused by Candida albicans.
  • Patients with CMC often exhibit associated disorders such as endocrine dysfunctions, alopecia, and malabsorption syndromes.
  • The underlying pathology frequently involves defects in cell-mediated immunity, specifically T-lymphocyte responses.

Purpose of the Study:

  • To define chronic mucocutaneous candidiasis and its associated clinical and immunological features.
  • To elucidate the role of cell-mediated immune abnormalities in predisposing individuals to opportunistic fungal infections.
  • To highlight the importance of addressing immunologic defects for effective treatment of CMC.

Main Methods:

Related Experiment Videos

  • Review of clinical and immunological data from patients diagnosed with chronic mucocutaneous candidiasis.
  • Analysis of the spectrum of associated disorders and opportunistic infections.
  • Correlation of immune system abnormalities with susceptibility to Candida spp. infections.

Main Results:

  • CMC is a syndrome defined by persistent Candida albicans infections, often accompanied by diverse systemic disorders.
  • Abnormalities in cell-mediated immunity, ranging from specific to generalized T-lymphocyte dysfunction, are prevalent in CMC patients.
  • These immunologic defects are the primary predisposing factors for opportunistic infections like candidiasis.

Conclusions:

  • Chronic mucocutaneous candidiasis is intrinsically linked to compromised cell-mediated immunity.
  • Conventional antifungal treatments provide temporary relief, with relapses common unless underlying immune system defects are addressed.
  • Correction of T-lymphocyte-mediated immune deficiencies is essential for sustained remission in chronic mucocutaneous candidiasis.